Clinical trials in Mauritius
54 studies list at least one site in Mauritius. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 34
- Recruiting
- 6
- Active, not recruiting
- 5
- Terminated
- 4
- Status unknown
- 3
- Not yet recruiting
- 2
Phase
- Phase 2
- 16
- Phase 3
- 11
- Phase 1
- 3
Most studied here
Who runs them
Cosmetique Active International (6) · Sanofi (6) · University of Mauritius (4) · Perrigo CSCI (3) · Pierre Fabre Dermo Cosmetique (3) · Vichy Laboratoires (2) · EMD Serono Research & Development Institute, Inc. (2) · Atea Pharmaceuticals, Inc. (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 54 — search for more.
- Genetic Analysis of Uncommon Disease Presentations in Non-US PopulationsRecruitingNCT06595940
- Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksRecruitingNCT07014007Not applicable
- Comparative Study for the Evaluation of a New Medical Device Shampoo on the Treatment of Head Lice InfestationNot yet recruitingNCT07391059Not applicable
- CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPICAL FORMULA ON DEPIGMENTATION OF LENTIGO SPOTSNot yet recruitingNCT07239726Not applicable
- Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal InfectionsRecruitingNCT07234786Not applicable
- COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYSRecruitingNCT07071363Not applicable
- Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice InfestationRecruitingNCT06057506Not applicable
- Omega-3 Supplementation to Both Parent and AdolescentRecruitingNCT05893550Phase 3
- Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusActive, not recruitingNCT05039840Phase 2
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.Active, not recruitingNCT06637631Phase 2
- Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular DiseaseActive, not recruitingNCT05030428Phase 3
- The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)Active, not recruitingNCT05540327Phase 2
- Evaluation of a Combination of Two Medical Devices and One Device Use in the Treatment of Toenail OnychomycosisCompletedNCT06175013Not applicable
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT04701983Phase 3
- Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 WeeksCompletedNCT07292467
- Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks RemanenceCompletedNCT07133334
- A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)TerminatedNCT05306574Phase 3
- The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)CompletedNCT05162586Phase 2
- A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB SubjectsCompletedNCT04536337Phase 1
- A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque PsoriasisCompletedNCT06073119Phase 2
- Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)CompletedNCT04029480Phase 3
- A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVCompletedNCT05904470Phase 2
- In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis SkinCompletedNCT07194421
- In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic DermatitisCompletedNCT07194408
- The Mauritius and Rodrigues Non-Communicable Disease (NCD) StudyActive, not recruitingNCT07048717
- A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid ArthritisCompletedNCT06073093Phase 2
- Clinical Efficacy of the Product in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP) SubjectsCompletedNCT06822335
- Efficacy of La Roche Posay Routine in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP)CompletedNCT06770127
- Phase 2b Study in NASH to Assess IVA337CompletedNCT03008070Phase 2
- Evaluation of Cicaplast in Subjects With Skin IrritationCompletedNCT05767333
- Efficacy Evaluation and Cutaneous Acceptability of the Lipikar Med Product on Subjects With Atopic DermatitisCompletedNCT05531188
- Cutaneous Acceptability, Comedogenic Potential and Efficacy of Two Cosmetic Products Used in SynergyCompletedNCT05490537
- Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice InfestationStatus unknownNCT05379114Not applicable
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02803918Phase 1
- Negative Pressure Wound Therapy in Diabetic WoundsCompletedNCT05041244Not applicable
- Self-Management of Type-2 Diabetes Using a Mobile ApplicationCompletedNCT05027334Not applicable
- A Phase II Study of M2951 in SLETerminatedNCT02975336Phase 2
- Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin AcneCompletedNCT02932267Phase 3
- Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) InfectionCompletedNCT04019717Phase 2
- Effect of Moringa Oleifera Infusion on HealthStatus unknownNCT04314258Not applicable
- Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate SunburnTerminatedNCT03332524Phase 2
- A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and SimeprevirCompletedNCT02569710Phase 2
- Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusCompletedNCT03427151Phase 3
- A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus ErythematosusCompletedNCT02504645Phase 3
- ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)CompletedNCT02955615Phase 2
- Effect of Remote Ischemic Conditioning in Heart Attack PatientsCompletedNCT02197117Not applicable
- African Surgical Outcomes Study (ASOS)CompletedNCT03044899
- Safety, PK and PD Study of ABX464 in Untreated HIV PatientsCompletedNCT02452242Phase 2
- Pyridorin in Diabetic NephropathyTerminatedNCT02156843Phase 3
- A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C PatientsCompletedNCT01928147Phase 1